LEWIS JOEL
SEC CIK 1725595 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GALT | GALECTIN THERAPEUTICS INC | Pres, CEO, Dir | 870.3K | $4,910 | $759.8K | 86 | 2021-06-30 | 2026-01-02 |
Most active insiders at GALT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | 10X Capital Management, LLC | 10% | — | $2.23M |
| 2 | Shlevin Harold H. | Dir | — | $1.56M |
| 3 | Jamil Khurram | Chief Medical Off | — | $1.44M |
| 4 | CALLICUTT JACK W | CFO | — | $944.3K |
| 5 | LEWIS JOEL | Pres, CEO, Dir | — | $620.9K |
| 6 | CZIRR JAMES C | 10% | — | $204.3K |
| 7 | FREEMAN KEVIN D | Dir | $58.6K | — |
| 8 | ELDRED KARY | Dir | $6,032 | — |
| 9 | Uihlein Richard E | Dir, 10% | — | — |
Transactions 86
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-01-06 | 2026-01-02 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | M - OptEx | $0.00 | +84.0K | 916.6K | +10% | $0 |
| DMT | 2026-01-06 | 2026-01-02+ | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | S - Sale+OE | $3.83 | -84.0K | 870.3K | -9% | -$321.4K |
| DT | 2025-12-19 | 2025-12-17 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | S - Sale+OE | $7.06 | -7,829 | 832.6K | -0.9% | -$55.3K |
| DT | 2025-12-19 | 2025-12-17 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | M - OptEx | $2.86 | +7,829 | 840.4K | +0.9% | +$22.4K |
| DMT | 2025-11-19 | 2025-11-17+ | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | M - OptEx | $2.39 | +22.5K | 839.4K | +3% | +$53.7K |
| DMT | 2025-11-19 | 2025-11-17+ | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | S - Sale+OE | $6.07 | -22.5K | 832.6K | -3% | -$136.4K |
| DT | 2025-11-12 | 2025-11-10 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | M - OptEx | $2.39 | +1,867 | 834.5K | +0.2% | +$4,462 |
| DT | 2025-11-12 | 2025-11-10 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | S - Sale+OE | $6.03 | -1,867 | 832.6K | -0.2% | -$11.3K |
| DT | 2025-11-07 | 2025-11-05 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | S - Sale+OE | $6.00 | -200 | 832.6K | -0.0% | -$1,200 |
| DT | 2025-11-07 | 2025-11-05 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | M - OptEx | $2.39 | +200 | 832.8K | +0.0% | +$478 |
| DMT | 2025-11-05 | 2025-11-03+ | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | M - OptEx | $2.39 | +15.7K | 847.0K | +2% | +$37.6K |
| DMT | 2025-11-05 | 2025-11-03+ | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | S - Sale+OE | $6.07 | -15.7K | 832.6K | -2% | -$95.3K |
| DT | 2025-09-15 | 2025-09-12 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | S - Sale+OE | $6.36 | -14.0K | 832.6K | -2% | -$89.0K |
| DT | 2025-09-15 | 2025-09-12 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | M - OptEx | $2.39 | +14.0K | 846.6K | +2% | +$33.5K |
| 2025-03-05 | 2025-03-03 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.57 | -56.4K | 832.6K | -6% | -$88.6K | |
| DT | 2024-12-26 | 2024-12-23 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | S - Sale+OE | $0.89 | -56.0K | 897.0K | -6% | -$49.8K |
| DT | 2024-12-26 | 2024-12-23 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | M - OptEx | $0.00 | +56.0K | 953.0K | +6% | $0 |
| I | 2024-04-25 | 2024-04-24 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | P - Purchase | $3.39 | +1,000 | 2,000 | +100% | +$3,390 |
| 2024-03-04 | 2024-03-01 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.96 | -152.6K | 897.7K | -15% | -$299.1K | |
| 2024-01-02 | 2023-12-29 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.66 | +11.6K | 1.04M | +1% | +$19.3K | |
| 2023-12-18 | 2023-12-15 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.60 | +12.0K | 1.03M | +1% | +$19.3K | |
| 2023-12-01 | 2023-11-30 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.95 | +9,880 | 1.02M | +1.0% | +$19.3K | |
| 2023-11-15 | 2023-11-15 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.87 | +10.3K | 1.01M | +1% | +$19.3K | |
| 2023-10-31 | 2023-10-31 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $2.04 | +9,444 | 998.5K | +1.0% | +$19.3K | |
| A | 2023-10-16 | 2023-10-13 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $2.01 | +9,585 | 989.0K | +1.0% | +$19.3K |
| 2023-10-16 | 2023-10-13 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $2.01 | +10.0K | 989.0K | +1% | +$20.2K | |
| 2023-10-02 | 2023-09-29 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.92 | +10.0K | 979.4K | +1% | +$19.3K | |
| 2023-09-18 | 2023-09-15 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.76 | +10.9K | 969.4K | +1% | +$19.3K | |
| 2023-09-01 | 2023-08-31 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.75 | +11.0K | 958.5K | +1% | +$19.3K | |
| 2023-08-15 | 2023-08-15 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.60 | +12.0K | 947.4K | +1% | +$19.3K | |
| 2023-07-31 | 2023-07-31 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.50 | +12.8K | 935.4K | +1% | +$19.3K | |
| 2023-07-17 | 2023-07-14 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.63 | +11.8K | 922.6K | +1% | +$19.3K | |
| 2023-07-03 | 2023-06-30 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.44 | +13.4K | 910.74 | New | +$19.3K | |
| 2023-06-16 | 2023-06-15 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.46 | +13.2K | 897.4K | +1% | +$19.3K | |
| 2023-06-01 | 2023-05-31 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.57 | +12.3K | 884.2K | +1% | +$19.3K | |
| 2023-05-16 | 2023-05-15 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.64 | +11.7K | 871.9K | +1% | +$19.3K | |
| 2023-05-09 | 2023-04-28 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.76 | +10.9K | 860.1K | +1% | +$19.3K | |
| 2023-04-17 | 2023-04-14 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $2.01 | +9,585 | 849.2K | +1% | +$19.3K | |
| 2023-04-03 | 2023-03-31 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $2.10 | +9,175 | 839.6K | +1% | +$19.3K | |
| 2023-03-16 | 2023-03-15 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.90 | +10.1K | 830.4K | +1% | +$19.3K | |
| 2023-03-02 | 2023-03-01 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | F - Tax | $2.07 | -75.5K | 820.3K | -8% | -$156.3K | |
| 2023-03-02 | 2023-02-28 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $2.07 | +9,308 | 895.8K | +1% | +$19.3K | |
| I | 2023-02-21 | 2023-02-16 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | P - Purchase | $1.52 | +1,000 | 1,000 | New | +$1,520 |
| 2023-02-15 | 2023-02-15 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.44 | +13.4K | 886.5K | +2% | +$19.3K | |
| 2023-02-07 | 2023-02-07 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.43 | +143.8K | 873.1K | +20% | +$205.7K | |
| 2023-01-31 | 2023-01-31 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.16 | +15.1K | 729.3K | +2% | +$17.5K | |
| 2023-01-17 | 2023-01-13 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.14 | +15.4K | 714.2K | +2% | +$17.5K | |
| 2023-01-03 | 2022-12-30 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.13 | +15.5K | 698.9K | +2% | +$17.5K | |
| 2022-12-15 | 2022-12-15 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.16 | +15.1K | 683.4K | +2% | +$17.5K | |
| 2022-12-01 | 2022-11-30 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.27 | +13.8K | 668.3K | +2% | +$17.5K | |
| 2022-11-15 | 2022-11-15 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.24 | +14.1K | 654.5K | +2% | +$17.5K | |
| 2022-11-01 | 2022-10-31 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.38 | +12.7K | 640.4K | +2% | +$17.5K | |
| 2022-10-17 | 2022-10-14 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.62 | +10.8K | 627.7K | +2% | +$17.5K | |
| 2022-10-03 | 2022-09-30 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.79 | +10.7K | 616.9K | +2% | +$19.2K | |
| A | 2022-10-03 | 2022-09-30 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.63 | +10.7K | 616.9K | +2% | +$17.5K |
| 2022-09-15 | 2022-09-15 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.79 | +9,777 | 606.2K | +2% | +$17.5K | |
| 2022-09-01 | 2022-08-31 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.90 | +9,211 | 596.4K | +2% | +$17.5K | |
| 2022-08-15 | 2022-08-15 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $2.18 | +8,028 | 587.2K | +1% | +$17.5K | |
| 2022-08-01 | 2022-07-29 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $2.26 | +10.6K | 552.1K | +2% | +$24.0K | |
| A | 2022-08-01 | 2022-07-29 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $2.26 | +7,743 | 552.1K | +1% | +$17.5K |
| 2022-07-18 | 2022-07-15 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.65 | +10.6K | 544.4K | +2% | +$17.5K | |
| 2022-07-01 | 2022-06-30 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.31 | +13.4K | 533.8K | +3% | +$17.5K | |
| 2022-06-16 | 2022-06-15 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.29 | +13.8K | 520.4K | +3% | +$17.8K | |
| 2022-06-01 | 2022-05-31 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.29 | +13.6K | 506.7K | +3% | +$17.5K | |
| 2022-05-16 | 2022-05-13 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.36 | +12.9K | 493.1K | +3% | +$17.5K | |
| 2022-05-02 | 2022-04-29 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.55 | +11.3K | 480.2K | +2% | +$17.5K | |
| 2022-04-18 | 2022-04-15 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.74 | +10.1K | 468.9K | +2% | +$17.5K | |
| 2022-03-31 | 2022-03-31 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.61 | +10.9K | 458.9K | +2% | +$17.5K | |
| 2022-03-16 | 2022-03-15 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.74 | +10.1K | 448.0K | +2% | +$17.5K | |
| 2022-03-01 | 2022-02-28 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.87 | +9,358 | 437.94 | New | +$17.5K | |
| 2022-02-15 | 2022-02-15 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $2.07 | +8,454 | 428.6K | +2% | +$17.5K | |
| 2022-02-01 | 2022-01-31 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.93 | +112.3K | 420.1K | +36% | +$216.7K | |
| 2022-01-18 | 2022-01-14 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $2.02 | +8,251 | 307.9K | +3% | +$16.7K | |
| 2022-01-03 | 2021-12-31 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $2.07 | +8,052 | 299.6K | +3% | +$16.7K | |
| 2021-12-15 | 2021-12-15 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $2.25 | +7,407 | 291.6K | +3% | +$16.7K | |
| 2021-12-01 | 2021-11-30 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $2.63 | +6,337 | 284.2K | +2% | +$16.7K | |
| 2021-11-15 | 2021-11-15 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $2.86 | +5,828 | 277.8K | +2% | +$16.7K | |
| 2021-11-01 | 2021-10-29 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $3.17 | +5,258 | 272.0K | +2% | +$16.7K | |
| 2021-10-18 | 2021-10-15 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $3.37 | +4,946 | 266.7K | +2% | +$16.7K | |
| 2021-09-30 | 2021-09-30 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $3.88 | +4,296 | 261.8K | +2% | +$16.7K | |
| 2021-09-16 | 2021-09-15 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $3.73 | +4,468 | 257.5K | +2% | +$16.7K | |
| 2021-09-01 | 2021-08-31 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $3.93 | +4,241 | 253.0K | +2% | +$16.7K | |
| 2021-08-16 | 2021-08-13 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $3.38 | +4,931 | 248.8K | +2% | +$16.7K | |
| 2021-08-02 | 2021-07-30 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $2.75 | +6,061 | 243.9K | +3% | +$16.7K | |
| 2021-07-16 | 2021-07-15 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $2.59 | +6,435 | 237.8K | +3% | +$16.7K | |
| 2021-07-02 | 2021-06-30 | GALT | GALECTIN THERAPEUTICS INC | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $3.20 | +5,208 | 231.4K | +2% | +$16.7K |
Purchase Sale Sale after option exercise All abbreviations